Literature DB >> 15868933

Differential expression of VEGF isoforms and VEGF receptors in cartilaginous tumors.

Kiminori Yukata1, Yoshito Matsui, Tomohiro Goto, Takahiro Kubo, Natsuo Yasui.   

Abstract

Vascular endothelial growth factor (VEGF), which is known to have at least five isoforms and four receptors, is integral to tumor-induced neovascularization. In order to determine whether VEGF signaling is modulated in the development of cartilaginous tumors, we analyzed osteochondrogenic tumors for the expression of VEGF isoforms and VEGF receptors using the reverse transcription-polymerase chain reaction method. Although mRNA for VEGF121, VEGF165, VEGFR-1 and NRP-2 was widely expressed, mRNA expression for VEGF189, VEGFR-2 and NRP-1 was linked to a malignant phenotype such as local invasion. These results indicated that VEGF signaling was fine-tuned by the differential expression of the VEGF isoforms and VEGF receptors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15868933

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  Neuropilin-1 is overexpressed in osteosarcoma and contributes to tumor progression and poor prognosis.

Authors:  H Zhu; H Cai; M Tang; J Tang
Journal:  Clin Transl Oncol       Date:  2013-12-12       Impact factor: 3.405

2.  Exosomal lncRNA RAMP2-AS1 Derived from Chondrosarcoma Cells Promotes Angiogenesis Through miR-2355-5p/VEGFR2 Axis.

Authors:  Cheng Cheng; Zhicai Zhang; Fuli Cheng; Zengwu Shao
Journal:  Onco Targets Ther       Date:  2020-04-20       Impact factor: 4.147

3.  Pazopanib in the Treatment of Bone Sarcomas: Clinical Experience.

Authors:  Ninna Aggerholm-Pedersen; Phillip Rossen; Hanne Rose; Akmal Safwat
Journal:  Transl Oncol       Date:  2019-12-23       Impact factor: 4.243

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.